Alzheimer's disease progression model using disability assessment for dementia scores from bapineuzumab trials.

Alzheimers Dement (N Y) · 2015 · PMC5975025 · PMID 29854934

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

appeared to be marginally significantno p-value reported

The trend was not found to be statistically significant among treatment groups, whereas the individual exposure-response relationship appeared to be marginally significant.

also in 12 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.